Prosecution Insights
Last updated: November 04, 2026
Application No. 18/286,897

A SYSTEM TO GENERATE A HIGH YIELD OF NEGATIVE IONS FOR ICP-MS

Final Rejection §102§103§112
Filed
Oct 13, 2023
Priority
Apr 11, 2022 — CA PCT/CA2022/050559 +1 more
Examiner
GASSEN, CHRISTOPHER J
Art Unit
2881
Tech Center
2800 — Semiconductors & Electrical Systems
Assignee
Kimia Analytics Inc.
OA Round
2 (Final)
80%
Grant Probability
Favorable
3-4
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 80% — above average
80%
Career Allowance Rate
115 granted / 143 resolved
+12.4% vs TC avg
Strong +24% interview lift
Without
With
+23.8%
Interview Lift
resolved cases with interview
Typical timeline
2y 9m
Avg Prosecution
30 currently pending
Career history
188
Total Applications
across all art units

Statute-Specific Performance

§101
3.9%
-36.1% vs TC avg
§103
41.6%
+1.6% vs TC avg
§102
17.8%
-22.2% vs TC avg
§112
33.6%
-6.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 143 resolved cases

Office Action

§102 §103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Response to Amendment The amendments filed 04/13/2026 have been entered. Claims 9, 12-14, and 19-20 have been canceled. Claims 1-8, 10-11, 15-18, and 21-30 are now pending in the application. Examiner notes that some of the amendments have not been properly indicated (i.e., strikethrough, underline, etc.), but because the omissions do not affect Examiner’s understanding of the claims, the claims have been entered as such. Response to Arguments Applicant’s amendments to the drawings have overcome each and every objection previously set forth in the Non-Final Office Action dated 01/14/2026, hereinafter NFOA0114. Applicant’s amendments to the specification have overcome each and every objection previously set forth in NFOA0114. However, one of Applicant’s amendments has introduced a new issue. See below for further discussion. Applicant’s amendments to the claims have overcome some, but not all, of the objections previously set forth in NFOA0114. See below for further discussion. Applicant’s amendments to the claims have overcome each and every 35 U.S.C. 112(a) rejection previously set forth in NFOA0114. Applicant’s amendments to the claims have overcome some, but not all, of the 35 U.S.C. 112(b) rejections previously set forth in NFOA0114. See below for further discussion. Examiner agrees that Applicant’s amendments to claims 11 and 18 have overcome the previously presented 35 U.S.C. 101 rejection. The amended claims have recited the natural processes integrated into a practical application (i.e., using the structure of the system/functional steps utilizing the natural processes). Specification The disclosure is objected to because of the following informalities: Applicant’s amendments to [23] have introduced a new issue, namely, “a meta-stable ions/neutrals” does not match in number. Appropriate correction is required. Claim Objections Claims 1, 3, 11, and 30 are objected to because of the following informalities: Claim 1 has been amended to ameliorate a previous issue regarding the walls of the cavity, however, the amendments have not properly overcome the issue; The claim now requires “a cavity having walls” and “wherein the plasma is capable of heating walls of the cavity”, but it is not clear whether ‘walls’ are the same walls as previously recited, and the claim subsequently recites ‘to prevent formation of deposits on the walls of the cavity’; Examiner believes this is a mere clerical/typographical error (i.e., a ‘double fix’: initialized the term walls to overcome previous issue, then also removed the reference back to the initialized term to overcome the previous issue, while only one of such edits was required to overcome the issue), and is thus definite in context, and should read ‘wherein the plasma is capable of heating the walls of the cavity’; Claim 3 recites “wherein the respective off-axis positions cause enhance mixing of…”, which does not make sense grammatically, and should read ‘wherein the respective off-axis positions cause enhanced mixing of…’; Claim 11 recites “an ionization energy lower than energy of the meta-stable energy state of…”, wherein ‘energy’ lacks an article, and should read, e.g., ‘an ionization energy lower than an energy of the meta-stable energy state of…’; Claim 11 recites “configured to transfer electrons to analytes to generate negative analyte ions…”, however, analytes are previously recited in claim 1, and no additional analytes are configured to be received via the inlet, and thus, Examiner believes this should read ‘configured to transfer electrons to the analytes to generate negative analyte ions…’; Claim 11 ends in two periods, as the previous period was not removed by amendment, and an additional was added via amendment; Claim 30 recites “the dopant or analytes”, however the claim previously recites “a dopant or an analyte”, and thus Examiner believes the limitation should read ‘the dopant or (the) analyte’. Appropriate correction is required. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 4-8, 10, 18, and 21-30 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Regarding claims 4-8, 10, 21-27 and 29-30, the same issue regarding dependencies is present as previously presented in NFOA0114, and are rejected similarly. Claims 6, 21-27, 29-30 each makes some reference to various of the numbered pressure stages ‘of the MS’, however, the claims do not previously require any of the pressure stages to be elements of the MS, and rather are recited as elements of the system, and in claim 1, the cavity is required to be included in an interface between the ICP source and the MS, rather than an element of either. Similarly, claim 15 requires that the mixture flows out of the cavity through one or more downstream pressure stages towards a mass spectrometer for analysis, similarly indicating that the cavity and pressure stages for mixing are not elements of the MS. As such, each of these recitations is unclear and it is not possible to adequately determine the metes and bounds of the claim, rendering it indefinite. For purposes of examination, this limitation is interpreted as though ‘of the MS’ is omitted in each case except the final recitation in claim 23, which is not unclear, as it recites downstream pressure stages of the MS in generality, rather than particular pressure stages which are previously required to be between the ICP source and the MS, and which one of ordinary skill in the art would understand in context. Claim 18 appears to be claiming a process which would naturally occur given the proper initial conditions, and it is thus unclear how this further limits the claim, as it is not directed toward any particular method steps. In particular, ‘performing penning ionization’ is indefinite, because the process of penning ionization is passive and would naturally occur if the meta-stable neutrals and proper dopant are placed in such a cavity. As such, it is not possible to adequately determine the metes and bounds of the claim, rendering it indefinite. Additionally, for clarity of the record, Examiner notes that the claim requiring the dopant ‘having’ such an ionization energy does not appear to recite an explicit method step, however, because claim 15 requires injecting the dopant, the dopant having such a property would thus limit the previously recited injection step. This portion of the claim is clear. For purposes of examination, the above limitation is interpreted as ‘further comprising allowing penning ionization inside the cavity to quench the meta-stable neutrals, wherein the dopant has an ionization energy less than an energy of the meta-stable energy state of the meta-stable neutrals, which facilitates quenching the meta-stable neutrals via penning ionization inside the cavity.’. As indicated above, the previously presented 35 U.S.C. 101 issue has been overcome because, under the broadest reasonable interpretation (BRI), and including the above interpretation, this claim now requires the limitation of the dopant injected, and such that the natural processes are phrased as functional consequences of the properties selected, rather than explicitly claiming the process (in view of the above interpretation). Claim 28 recites the limitation “wherein the first cavity inlet and the cavity outlet are positioned to achieve an off-axis cavity configuration, and wherein a lower pressure is maintained downstream of the cavity outlet so as to cause a flow path of the plasma to bend from the first cavity inlet toward the cavity outlet, thereby blocking photons from entering the MS”, which is vague and indefinite because the claim does not provide a discernable boundary on what is required by the claim to achieve the desired functionality. In particular “wherein the first cavity inlet and the cavity outlet are positioned to achieve an off-axis cavity configuration” does not particularly limit the inlets positioning, as no particular axes are referred to or required in the claims, and thus ‘an off-axis cavity configuration’ in unclear, as such a cavity would be understood as having an infinite number of potential axes in three dimensions, and thus it is not clear what ‘off-axis’ would require, and furthermore, how the positioning of the inlets would affect the on- or off-axis configuration of the cavity as a whole. Additionally, because of such issues, it is unclear how the required arrangement would ‘cause a flow path of the plasma to bend from the first cavity inlet toward the cavity outlet, thereby blocking photons from entering the MS’, as no positional relationship of the inlets relative to one another is required in the claim, and how the bending of the flow path would achieve ‘blocking photons from entering the MS’. It is unclear whether the function requires some other specific positioning to achieve such bending and blocking of the respective particles, or whether providing such a pressure difference would be all that is required to bend and block the respective particles. As such, it is not possible to adequately determine the metes and bounds of the claim, rendering it indefinite. For purposes of examination, this limitation is interpreted as ‘wherein the first cavity inlet and the cavity outlet are positioned along a different axis from the cavity outlet, and wherein a lower pressure is maintained downstream of the cavity outlet so as to cause a flow path of the plasma to bend from the first cavity inlet toward the cavity outlet, thereby blocking photons from entering the MS.’. Claim 29 recites “further comprising introducing the dopant at one or more of the pressure stages of the MS, wherein the injection of dopant in proximity to the meta-stable neutrals causes an interaction therebetween…”, however, the claim previously requires ‘injecting a dopant into the cavity’, and one of ordinary skill in the art would understand ‘introducing the dopant at one or more of the pressure stages’ as being functionally equivalent to ‘injecting’ and thus the subsequent recitation of ‘the injection of dopant’ is ambiguous. As such, it is not possible to adequately determine the metes and bounds of the claim, rendering it indefinite. For purposes of examination, this limitation is interpreted as ‘further comprising introducing the dopant at one or more of the pressure stages of the MS, whereby the dopant is injected in proximity to the meta-stable neutrals to cause an interaction therebetween…’. Claims that depend on the above rejected claims are also rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claims 1-2, 15-16, and 18 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Sakata (USPN US 6265717 B1). Regarding claim 1, Sakata teaches an inductively coupled plasma mass spectrometer (ICP-MS) system (See Fig. 1; Col. 4, line 26 – Col. 5, line 25), comprising: - an inductively coupled plasma (ICP) source having at least one inlet to receive a background gas and analytes (See Fig. 1, item 130, receiving Ar and sample; Col. 2, line 35 – Col. 3 line 67; Col. 4, line 26 – Col. 5, line 25), wherein the inductively coupled plasma (ICP) source is configured to at least partially ionize the background gas and generate a plasma, the plasma comprising positive and negative ions, meta-stable ions, meta-stable neutrals, molecules of the background gas, and free electrons (Col. 4, lines 31-46; Examiner notes that the plasma excited Ar and sample ions would naturally include each of these elements); - a mass spectrometer (MS) (See Fig. 1, items 160, 170, 180; Col. 4, line 64 – Col. 5, line 25); - an interface between the ICP source and the MS, comprising a cavity having walls (See Figs. 1-5; Col. 4, lines 46-63), the cavity including: a first cavity inlet fluidically coupled to the ICP source to receive the plasma and the background gas (See Figs. 1-5, via sampling cone 151 and sampling orifice 152; Col. 4, lines 46-63); a second cavity inlet configured to receive a dopant and analytes (See Figs. 1-5, and in particular, Fig. 3, item 210; Col. 5, line 49 – Col. 6, line 7; Examiner notes that the inlet is capable of receiving dopant and analytes); a cavity outlet fluidically coupled to the MS (See Figs. 1-5, via skimmer cone 155 and skimmer orifice 156; Col. 5, line 49 – Col. 6, line 7); wherein the cavity is configured to mix and react the dopant, the plasma, and the analytes to form a mixture (See Figs. 1-5, item 150; Col. 5, line 49 – Col. 6, line 7; Examiner notes that the cavity is capable of mixing such elements); wherein the plasma is capable of heating walls of the cavity to prevent formation of deposits on the walls of the cavity (Examiner notes that an ordinarily skilled artisan would understand the disclosed ICP of Sakata are being capable of heating the walls of the cavity, inherently, as such ICPs regularly achieve temperatures of several thousand K), and whereby no electrostatic or magnetic fields are applied inside the cavity (See Figs. 1-5, item 150; Col. 5, line 49 – Col. 6, line 7;). Regarding claim 2, Sakata teaches the system of claim 1. Sakata further teaches wherein the cavity defines a first pressure stage of the system that is maintained at a pressure lower than atmosphere (Col. 2, line 47 – Col. 3, line 67). Regarding claim 15, Sakata teaches a method for quenching meta-stable neutrals and generating negative ions for an inductively coupled plasma mass spectrometer (ICP-MS), comprising: a. injecting a background gas and analytes into an ICP torch to form a plasma comprising positive and negative ions, meta-stable ions, meta-stable neutrals, molecules of the background gas, and free electrons (Col. 4, lines 31-46; Examiner notes that the plasma excited Ar and sample ions would naturally include each of these elements); b. sampling the plasma into a cavity sustained at a pressure lower than atmosphere through a first cavity inlet (See Figs. 1-5, and in particular, Fig. 3, via 151, 152; Col. 2, line 47 – Col. 3, line 67; Col. 4, lines 46-63); c. injecting a dopant into the cavity through a second cavity inlet (See Figs. 1-5, and in particular, Fig. 3, via 210; Col. 2, line 47 – Col. 3, line 67; Col. 4, lines 46-63); d. mixing the plasma and the dopant inside the cavity to quench the meta-stable neutrals and form a mixture (See Figs. 1-5, and in particular, Fig. 3, via 210; Col. 2, line 47 – Col. 3, line 67; Col. 4, lines 46-63; Examiner notes that such placing the disclosed gases through the second inlet with the plasma mixture will naturally quench the Ar meta-stable neutrals), and e. allowing the mixture to flow out of the cavity by the momentum of the background gas under the influence of a pressure differential between the cavity and one or more downstream pressure stages (See Fig. 1, having multiple pressure stages; Col. 2, line 47 – Col. 3, line 67; Examiner notes that the disclosed pressure stage arrangement will cause the mixture to flow out of cavity 150 via the pressure differential), whereby the mixture flows out of the cavity via a cavity outlet (See Fig. 1-5, and in particular Fig. 3, via 155, 156), and is subsequently allowed to flow through the one or more downstream pressure stages towards a mass spectrometer for analysis (See Fig. 1, items 160, 170, 180; Col. 4, line 64 – Col. 5, line 25). Regarding claim 16, Sakata teaches the method of claim 15. Sakata further teaches wherein the background gas comprises helium (He), nitrogen (N2), argon (Ar), oxygen (02), hydrogen (H2), air, water vapor, or a combination thereof (Col. 5, lines 25-48; See also examples). Regarding claim 18, Sakata teaches the method of claim 15. Sakata further teaches further comprising performing penning ionization inside the cavity to quench the meta-stable neutrals, wherein the dopant has an ionization energy less than an energy of the meta-stable neutrals, which facilitates quenching the meta-stable neutrals via penning ionization inside the cavity (See Figs. 1-5; Col. 4, lines 46-63; Examiner notes that the gases disclosed have a lower ionization energy than meta-stable Ar neutrals, and thus would naturally quench the meta-stable neutrals upon interaction, via penning ionization; See: Sharma, cited below, for Ar excitation values). Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 3, 11, 17, and 28 are rejected under 35 U.S.C. 103 as being unpatentable over Sakata (USPN US 6265717 B1). Regarding claim 3, Sakata teaches the system of claim 1. Sakata further teaches wherein analytes inside the cavity and prevent photons from entering the MS (See Figs. 1-5; Col. 4, lines 46-63; Examiner notes that such an off-axis position of 210 causes such mixing, and is explicitly disclosed as helping to prevent undesired elements from entering the analysis stage). Sakata does not explicitly teach wherein the first and the second cavity inlets are each in a respective off-axis position with respect to the cavity outlet. However, because Sakata discloses such a structure with such a functionality applied for a similar purpose, it is Examiner’s opinion that it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have modified Sakata to include both inlets being off axis from the outlet, rather than only the second inlet. Doing so represents applying a technique disclosed in Sakata in the same manner for a disclosed elements of Sakata in a manner that would achieve predictable results, namely, increased ion collisions and decreased spectral interferences. Regarding claim 11, Sakata teaches the system of claim 1. Sakata further teaches wherein the dopant has an ionization energy lower than energy of the meta-stable energy state of the meta-stable neutrals, such that the system is configured to passively quench the meta-stable neutrals via interaction with the dopant (See Figs. 1-5; Col. 4, lines 46-63; Examiner notes that the gases disclosed have a lower ionization energy than meta-stable Ar neutrals, and thus would naturally quench the meta-stable neutrals upon interaction; See: Sharma, cited below, for Ar excitation values), whereby dopant and free electrons within the system are configured to interact to form negatively charged dopant via electron attachment, and the negatively charged dopant are further configured to transfer electrons to analytes to generate negative analyte ions within one or more pressure stages of the system[Examiner notes that these processes would naturally occur given a such a naturally charged dopant, which would naturally occur from interaction with such Ar meta-stable neutrals in such a plasma mixture). However, Sakata discloses the gas being introduced such that increased ion collisions occur, and such that undesired spectral interferences are ‘quenched’. Furthermore, an ordinarily skilled artisan in this context would have an advanced degree in a physical science/engineering, or equivalent experience, and thus would have a relatively high level of ordinary skill and knowledge. Accordingly, such a skilled artisan would readily recognize that combining a substance with a lower ionization energy with the meta-stable neutrals would naturally cause the substance to become ionized, and that the increased ion interactions would naturally cause ionization of sample particles/molecules in the vicinity according to natural processes. Regarding claim 17, Sakata teaches the method of claim 15. Sakata further teaches wherein the dopant has an ionization energy lower than an energy of the meta-stable energy state of the meta-stable neutrals, which comprise Ar meta-stable neutrals (See Figs. 1-5; Col. 4, lines 46-63; Examiner notes that the gases disclosed have a lower ionization energy than meta-stable Ar neutrals, and thus would naturally quench the meta-stable neutrals upon interaction; See: Sharma, cited below, for Ar excitation values), and wherein the dopant comprises Butenal, Butene, Butyne, Allene, Acetone, Propene, Ammonia, Pentyne, Hexane, Methylene, Ethylene, Hexane, Formic acid, or a combination thereof; and wherein mixing the dopant and the Ar meta-stable neutrals quenches the Ar meta-stable neutrals and forms ionized dopant (Examiner notes that mixing such a dopant and Ar meta-stable neutrals naturally quenches the Ar meta-stable neutrals and forms ionized dopant). Sakata does not explicitly teach wherein the dopant comprises Butenal, Butene, Butyne, Allene, Acetone, Propene, Ammonia, Pentyne, Hexane, Methylene, Ethylene, Hexane, Formic acid, or a combination thereof, however, each of these substances are ubiquitous substances with well-known properties, and in particular, having an ionization energies lower than an energy of the meta-stable energy state of the meta-stable neutrals. Accordingly, because Sakata discloses such a dopant having such a required property to achieve the necessary functionality, it is Examiner’s opinion that it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have modified Sakata to include wherein the dopant comprises Butenal, Butene, Butyne, Allene, Acetone, Propene, Ammonia, Pentyne, Hexane, Methylene, Ethylene, Hexane, Formic acid, or a combination thereof, as opposed to the disclosed gases. Doing so represents substituting one element for another in order to achieve predictable results, and represents merely choosing between a group of well-known potential alternatives, which could be done via routine experimentation, as an ordinarily skilled artisan could readily determine the necessary ionization energy necessary, could readily identify a finite number of known suitable alternatives (i.e., common often relatively inexpensive gases having the required ionization properties, which would be known (e.g., see Sharma), and could test the performance such gases via routine experimentation. Such an ordinarily skilled artisan would be readily apprised of each of these substances, could readily determine the ionization energies therefrom, and could readily replace the disclosed gases with such an alternative with a reasonable expectation of success, and achieving predictable results, namely, similar removal of spectral interferences. Regarding claim 28, as best understood in view of the 35 U.S.C. 112(b) issues identified above, Sakata teaches the method of claim 15. Sakata further teaches wherein the [second] cavity inlet and the cavity outlet are positioned to achieve an off-axis cavity configuration, and wherein a lower pressure is maintained downstream of the cavity outlet so as to cause a flow path of the plasma to bend from the [second] cavity inlet toward the cavity outlet, thereby blocking photons from entering the MS (See Figs. 1-5; Col. 2, line 47 – Col. 3, line 67; Col. 4, lines 46-63; Examiner notes that such an off-axis position of 210 causes such mixing, and is explicitly disclosed as helping to prevent undesired elements from entering the analysis stage; Examiner further notes that the flow path would naturally bend due to the pressure difference). Sakata does not explicitly teach wherein the first cavity inlet and the cavity outlet are positioned to achieve an off-axis cavity configuration, and wherein a lower pressure is maintained downstream of the cavity outlet so as to cause a flow path of the plasma to bend from the first cavity inlet toward the cavity outlet, thereby blocking photons from entering the MS. However, because Sakata discloses such a structure with such a functionality applied for a similar purpose, it is Examiner’s opinion that it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have modified Sakata to include the first inlets being off axis from the outlet, rather than only the second inlet. Doing so represents applying a technique disclosed in Sakata in the same manner for a disclosed elements of Sakata in a manner that would achieve predictable results, namely, increased ion collisions and decreased spectral interferences. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure: O’Connor (O’Connor, Gavin, and E. Hywel Evans. "Fundamental Aspects of Inductively Coupled Plasma–Mass Spectrometry (ICP-MS)." Inductively coupled plasma spectrometry and its applications (2007): 134.) Sharma (Lalita Sharma et al 2007 J. Phys.: Conf. Ser. 80 012019). Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to CHRISTOPHER J GASSEN whose telephone number is (571)272-4363. The examiner can normally be reached M-F 9-5. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, ROBERT H KIM can be reached at (571)272-2293. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /CHRISTOPHER J GASSEN/Examiner, Art Unit 2881 /DAVID E SMITH/Examiner, Art Unit 2881
Read full office action

Prosecution Timeline

Oct 13, 2023
Application Filed
Jan 14, 2026
Non-Final Rejection mailed — §102, §103, §112
Apr 13, 2026
Response Filed
Sep 25, 2026
Final Rejection mailed — §102, §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12770753
TERMINALLY STERILIZED ALPHA-EMITTING ISOTOPE GENERATOR AND METHOD FOR PRODUCING TERMINALLY STERILIZED ALPHA-EMITTING ISOTOPE
2y 10m to grant Granted Oct 20, 2026
Patent 12700561
MANIPULATOR, MANIPULATOR ARRAY, CHARGED PARTICLE TOOL, MULTI-BEAM CHARGED PARTICLE TOOL, AND METHOD OF MANIPULATING A CHARGED PARTICLE BEAM
3y 7m to grant Granted Aug 04, 2026
Patent 12671054
Adjustable Permanent Magnetic Lens Having Shunting Device
3y 1m to grant Granted Jun 30, 2026
Patent 12665165
METHOD FOR PREPARING A MICROSCOPIC SAMPLE FOR FIB/SEM TOMOGRAPHY
2y 8m to grant Granted Jun 23, 2026
Patent 12646679
APPARATUS FOR AND METHOD OF CONTROL OF A CHARGED PARTICLE BEAM
3y 11m to grant Granted Jun 02, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
80%
Grant Probability
99%
With Interview (+23.8%)
2y 9m (~0m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 143 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month